- Home
- FluxMPS™ Minimum Essential Medium (MEM), Low Glucose, NEAA & 25mM HEPES w/o L-Glutamine, Sodium Pyruvate: 1X Liquid
FluxMPS™ Minimum Essential Medium (MEM), Low Glucose, NEAA & 25mM HEPES w/o L-Glutamine, Sodium Pyruvate: 1X Liquid
FluxMPS™ DCP-MEMH-QP1X is an MPS-grade, ultra-filtered MEM Low Glucose + NEAA + 25mM HEPES formulation engineered for Primary fibroblasts and related cell models on organ-on-a-chip (OoC) and microphysiological system (MPS) platforms. Processed through a Quadruple-stage filtration system (0.1 µm ×2 + 0.04 µm ×2), it delivers approximately 5× lower particulate counts than conventional 0.22 µm–filtered media. NEAA pre-loaded — reduces metabolic burden on primary cells. HEPES (25 mM, pKa 7.3 at 37°C) provides robust CO₂-independent pH buffering. Formulation: [+] Earle's Salts, [+] NEAA, [+] Low Glucose (1000 mg/L), [+] Sodium Bicarbonate, [+] 25mM HEPES | [-] L-Glutamine, [-] Sodium Pyruvate.
- Low Glucose (1.0 g/L) — physiological carbon source for primary cells sensitive to high glucose.
- NEAA included reduces metabolic burden and ammonia from de novo synthesis
- 25 mM HEPES (pKa 7.3 at 37°C) — pH-stable without CO₂; ideal for open-air handling, flow cytometry prep, and atmospheric incubation
- 0.04 µm final nano-filtration — sub-mycoplasma purity; < 0.05 EU/mL endotoxin for sensitive primary and hematopoietic cell cultures
- Quadruple-stage filtration: 0.1 µm pre-I → 0.04 µm pre-II → 0.1 µm sterile-I → 0.04 µm final polish
- Ultrapure Type 1 water (18.2 MΩ·cm), ISO 13485:2016 QMS, ISO Class 5 fill
- Media familyMEM Low Glucose + NEAA + 25mM HEPES
- Glucose1000 mg/L (1.0 g/L, Low Glucose)
- HEPES25 mM, pKa 7.3 at 37°C
- NEAAPresent
- Formulation[+] Earle's Salts, [+] NEAA, [+] Low Glucose, [+] Sodium Bicarbonate, [+] 25mM HEPES
[-] L-Glutamine, [-] Sodium Pyruvate - AppearanceOrange-to-Red colored, clear solution
- pH (USP <791>)7.4
- Osmolality (USP <785>)290.00 — 330.00 mOsm/kg H₂O
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1 μm ×2 + 0.04 μm ×2
Engineered for primary cell culture where standard media fails
MEM with Earle's Salts is the primary cell biologist's medium — but conventional 0.22 μm filtered MEM passes mycoplasma, particulates, and endotoxin that alter primary cell phenotype. FluxMPS™ eliminates these failure modes while preserving the full nutritional profile primary cells depend on.
Microchannel-safe purity
0.04 µm final filtration; USP <788> particulate compliance. Particle-free primary cell media prevents chip channel clogging and mycoplasma-driven phenotypic drift.
Primary cell—optimized formulation
MEM + Earle's Salts + NEAA: the established standard for primary fibroblasts, neurons, epithelial, and vascular cells.
HEPES: CO₂-stable pH
25 mM HEPES prevents pH rise during open-air suspension culture handling, flow cytometry prep, and multi-well assay setup outside CO₂ incubators.
Below TLR4 endotoxin threshold
< 0.05 EU/mL endotoxin — below the TLR4 activation threshold. For primary cells, prevents LPS-driven fibroblast activation, neuroinflammation, and epithelial barrier disruption.
NEAA reduces metabolic burden
Pre-loaded NEAA reduces de novo synthesis burden on primary cells, improving viability in low-serum conditions and reducing ammonia accumulation.
Customization on demand
pH, glucose, HEPES concentration, and component modifications available. Contact support@diagnocine.com.
Quadruple-stage filtration system
Four serial filtration stages reaching a final 0.04 µm polish under ISO Class 5 aseptic conditions.
-
1
0.1 μm Pre-filtration I — Large Particulate Removal
Removes large aggregates; protects downstream 0.04 µm membranes.
-
2
0.04 μm Pre-filtration II — Mycoplasma Barrier
Retains mycoplasma (0.1—0.3 µm) — absent from standard 0.22 µm filtration.
-
3
0.1 μm Sterile-filtration I — Second-pass Redundancy
Second-pass sterility redundancy; no breakthrough from Stage 1.
-
4
0.04 μm Sterile-filtration II — Final Polish
Ultimate sub-mycoplasma polish; ISO Class 5 aseptic fill & finish.
Performance vs. conventional media
FluxMPS™ DCP-MEMH-QP1X delivers approximately 5× lower particulate counts than standard 0.22 µm filtered media, with confirmed mycoplasma barrier at every production stage.
© Diagnocine® — DCP-MEMH-QP1X
Primary cell models and OoC applications
FluxMPS™ DCP-MEMH-QP1X is purpose-built for Primary fibroblasts and related cell models with 0.04 µm filtration purity for microfluidic platform compatibility.
Automated Bioreactors & Robotics
Optional 0.01 µm (10 nm) ultra-filtered variant available on request.
- Total Particulate Exclusion: 10 nm filtration removes nanoparticulate aggregates
- Valve & Sensor Protection: Eliminates micro-fouling in delicate chip geometries
- Extended Perfusion Stability: Consistent nutrient delivery over long-duration culture
Inquiry Required: Contact support@diagnocine.com for the 0.01 µm variant.
Neuronal Chips & Brain-on-Chip
MEM + Earle’s Salts + NEAA + low glucose is the physiological-closest base for primary cortical neurons, DRG neurons, and iPSC-derived neuronal networks in compartmentalized chips.
Epithelium-on-Chip
Low-glucose MEM with NEAA supports primary epithelial cells and their barrier integrity in transwell and microfluidic TEER-monitored platforms.
Primary Fibroblast & Stromal Models
MEM with NEAA is the classical base for primary dermal, lung, and cardiac fibroblasts in low-serum or serum-free OoC conditions.
Vascular Cell Culture
Earle’s salt ionic balance supports vascular smooth muscle cells and primary endothelial co-culture models on vascular-on-chip platforms.
Organ-on-a-Chip & MPS
0.04 µm filtered MEM prevents particulate clogging in sub-100 µm neuronal and epithelial chip microchannels.
Microscopy & Optical Sensing
Ultra-low particulate; phenol red—free variants eliminate autofluorescence for confocal, TEER sensor, and biosensor applications on primary cell chips.
Analytical release specifications
Every lot released against the full specification matrix. CoA: support@diagnocine.com.
| Parameter | Specification |
|---|---|
| Formulation | [+] Earle's Salts, [+] NEAA, [+] Low Glucose (1000 mg/L), [+] Sodium Bicarbonate, [+] 25mM HEPES | [-] L-Glutamine, [-] Sodium Pyruvate |
| Appearance | Orange-to-Red colored, clear solution |
| Glucose | 1000 mg/L (1.0 g/L, Low Glucose) |
| HEPES | 25 mM (5958 mg/L), pKa 7.3 at 37°C |
| NEAA | Present |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 290.00—330.00 mOsm/kg H₂O |
| Total ingredients | 35 |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> BET | < 0.05 EU/mL |
| Sterility USP <71> | No growth / 14 days |
| Mycoplasma | Negative (0.04 µm barrier) |
| Particulate ≥10 µm USP <788> | NMT 25/mL |
| Particulate ≥25 µm USP <788> | NMT 3/mL |
| Water purity | Type 1, 18.2 MΩ·cm |
| Manufacturing std. | ISO 13485:2016 |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage temperature | 2—8°C, away from light |
| Freeze-thaw | Do not freeze |
| Shelf life | 12 months from manufacture |
| Shipping condition | Cold pack |
| CO₂ requirement | 5% CO₂ recommended (dual HEPES + bicarbonate buffering; HEPES alone maintains pH without CO₂) |
| Parameter | Specification |
|---|---|
| Raw material grade | Reagent / cell culture grade |
| Traceability | Full lot traceability per ISO 13485 |
| Manufacturing QMS ISO | ISO 13485:2016 certified |
| Regulatory alignment | 21 CFR Part 820 (cGMP) aligned |
| Production method | Micro-batch, per-lot QC release |
| Intended use | Research Use Only (RUO) |
Full composition (mg/L)
MEM Low Glucose + NEAA + 25mM HEPES: 35 ingredients verified per lot with CAS numbers. NEAA listed under AMINO ACIDS. HEPES (25 mM = 5958 mg/L, CAS 7365-45-9) listed under OTHERS.
| Component | CAS Number | mg/L |
|---|---|---|
| INORGANIC SALTS | ||
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Magnesium sulphate anhydrous | 7487-88-9 | 97.720 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium bicarbonate | 144-55-8 | 2200.000 |
| Sodium chloride | 7647-14-5 | 6800.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 122.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| AMINO ACIDS | ||
| Glycine | 56-40-6 | 7.500 |
| L-Alanine | 56-41-7 | 8.900 |
| L-Arginine hydrochloride | 1119-34-2 | 126.000 |
| L-Asparagine monohydrate | 5794-13-8 | 15.000 |
| L-Aspartic acid | 56-84-8 | 13.300 |
| L-Cystine dihydrochloride | 30925-07-6 | 31.300 |
| L-Glutamic acid | 56-86-0 | 14.700 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 42.000 |
| L-Isoleucine | 73-32-5 | 52.000 |
| L-Leucine | 61-90-5 | 52.000 |
| L-Lysine hydrochloride | 657-27-2 | 72.500 |
| L-Methionine | 63-68-3 | 15.000 |
| L-Phenylalanine | 63-91-2 | 32.000 |
| L-Proline | 147-85-3 | 11.500 |
| L-Serine | 56-45-1 | 10.500 |
| L-Threonine | 72-19-5 | 48.000 |
| L-Tryptophan | 73-22-3 | 10.000 |
| L-Tyrosine disodium salt dihydrate | 69847-15-0 | 51.900 |
| L-Valine | 72-18-4 | 46.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 1.000 |
| D-Ca-Pantothenate | 137-08-6 | 1.000 |
| Folic acid | 59-30-3 | 1.000 |
| Nicotinamide | 98-92-0 | 1.000 |
| Pyridoxal hydrochloride | 65-22-5 | 1.000 |
| Riboflavin | 83-88-5 | 0.100 |
| Thiamine hydrochloride | 67-03-8 | 1.000 |
| i-Inositol | 87-89-8 | 2.000 |
| OTHERS | ||
| D-Glucose | 50-99-7 | 1000.000 |
| HEPES | 7365-45-9 | 5958.000 |
Manufacturing & compliance
Every FluxMPS™ product manufactured and released under a rigorous multi-layer quality system.
ISO 13485:2016 Quality Management
Manufactured under ISO 13485:2016–certified and CE-approved facilities. Final QA at DiagnoCine R&D Center, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm — eliminates ionic contaminants.
ISO Class 5 Fill & Finish
Aseptic fill in validated ISO Class 5 (Class 100) laminar-flow workstations.
Micro-Batch Precision
Small-batch, per-lot tested — no blending, Certificate of Analysis for every lot.
Endotoxin — USP <85> BET
LAL assay < 0.05 EU/mL per lot.
Particulate — USP <788> Method 2
≤25/mL (≥10 µm), ≤3/mL (≥25 µm).
Osmolality — USP <785>
Target: 290.00—330.00 mOsm/kg H₂O.
Documentation & CoA
Full CoA with raw-material traceability available for every lot on request.
How DCP-MEMH-QP1X compares
FluxMPS™ DCP-MEMH-QP1X vs. conventional 0.22 µm–filtered MEM Low Glucose + NEAA + formulations.
| Parameter | DCP-MEMH-QP1X (FluxMPS™) | Conventional MEM Low Glucose (0.22 μm filtered) |
Standard DMEM (0.22 μm) |
|---|---|---|---|
| MEM + NEAA + 25mM HEPES — no L-Glutamine and no Pyruvate; dual metabolic control with stable pH | check_circle Yes | cancel No | cancel No |
| Final filtration pore size | 0.04 μm | 0.22 μm | 0.22 μm |
| Number of filtration stages | 4 (Quadruple) | 1 | 1 |
| Mycoplasma barrier | check_circle Yes (0.04 μm) | cancel No | cancel No |
| HEPES (25 mM) included | check_circle Yes | cancel Usually no | cancel No |
| NEAA included | check_circle Yes | Optional add-on | cancel No |
| Endotoxin specification | < 0.05 EU/mL | NMT 1 EU/mL | NMT 1 EU/mL |
| USP <788> particulate tested | check_circle Yes | cancel No | cancel No |
| Water quality | Type 1, 18.2 MΩ·cm | Purified water | Purified water |
| Manufacturing QMS | ISO 13485:2016 | ISO 9001 or none | ISO 9001 or none |
| Microfluidic channel compatible | check_circle MPS-grade | cancel Risk of clogging | cancel Risk of clogging |
Frequently asked questions
Common questions about FluxMPS™ DCP-MEMH-QP1X.
Supporting literature
Key publications supporting MEM Low Glucose + NEAA + 25mM HEPES in primary cell OoC applications.
- Eagle H. Amino acid metabolism in mammalian cell cultures. Science. 1959;130:432—437.doi:10.1126/science.130.3373.432
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662—1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760—772. doi:10.1038/nbt.2989
- Novak R, et al. Robotic fluidic coupling and interrogation of multiple vascularized organ chips. Nat Biomed Eng. 2020;4:407—420. doi:10.1038/s41551-019-0497-x
- Campisi M, et al. 3D self-organized microvascular model of the human blood-brain barrier. Biomaterials. 2018;180:117—129. doi:10.1016/j.biomaterials.2018.07.014
- Jang KJ, et al. Human kidney proximal tubule-on-a-chip. Integr Biol. 2013;5:1119—1129. doi:10.1039/c3ib40049b
- Schimek K, et al. Integrating biological vasculature into a multi-organ-chip microsystem. Lab Chip. 2013;13:3588—3598. doi:10.1039/c3lc50217a
- Luni C, et al. High-efficiency cellular reprogramming with microfluidics. Nat Methods. 2016;13:446—452. doi:10.1038/nmeth.3832
- Sung JH, et al. Microfabricated mammalian organ systems. Lab Chip. 2013;13:1201—1212. doi:10.1039/c3lc41017j





